Search

Search Constraints

You searched for: Author/Creator Wang, Junsheng

Search Results

1. 659 AN SINGLE-ARM OPEN-LABEL PHASE II STUDY OF CAMRELIZUMAB PLUS APATINIB AS SECOND-LINE TREATMENT FOR ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA. (17th September 2021)

10. Biocompatible linear diamides derivative-nucleated biodegradable poly(ethylene succinate): Tailored crystallization kinetics, aggregated structure and thermal degradation. (January 2021)